etofibrate has been researched along with Myocardial Infarction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Briel, M; Ferreira-González, I; Jakob, T; Nordmann, AJ; Schandelmaier, S | 1 |
| Geró, S; Horváth, M; Jósfay, A; Mezey, Z; Nánay, I; Varsányi, M | 1 |
1 review(s) available for etofibrate and Myocardial Infarction
| Article | Year |
|---|---|
Fibrates for primary prevention of cardiovascular disease events.
Topics: Atorvastatin; Bezafibrate; Cardiovascular Diseases; Clofibric Acid; Fenofibrate; Gemfibrozil; Humans; Hypolipidemic Agents; Middle Aged; Myocardial Infarction; Primary Prevention; Simvastatin; Stroke | 2016 |
1 other study(ies) available for etofibrate and Myocardial Infarction
| Article | Year |
|---|---|
The effect of some drugs on in vitro cellular immune reactions and on circulating immune complexes in patients with myocardial infarction.
Topics: Aged; Antigen-Antibody Complex; Aorta; Cell Migration Inhibition; Clofibric Acid; Cyclosporine; Female; Humans; Hypolipidemic Agents; Immunity, Cellular; In Vitro Techniques; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Nifedipine | 1991 |